about
FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.UBE2S is associated with malignant characteristics of breast cancer cells.TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion.SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.Erratum to: UBE2S is associated with malignant characteristics of breast cancer cells.Proliferating cell nuclear antigen as a molecular biomarker for spermatogenesis in PTU-induced hypothyroidism of rats.Synthesis, spectroscopic, thermal and molecular modeling studies of Zn2+, Cd2+ and UO22+ complexes of Schiff bases containing triazole moiety. Antimicrobial, anticancer, antioxidant and DNA binding studies.Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition.Folic acid alleviates oxidative stress and hyperhomocysteinemia involved in testicular dysfunction of hypothyroid rats.Erratum to: FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion and colony formation.The phospholipid PI(3,4)P is an apical identity determinantUbiquitination: Friend and foe in cancerDual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinomaCombination of arsenic trioxide and cisplatin synergistically inhibits both hexokinase activity and viability of Ehrlich ascites carcinoma cells
P50
Q32884438-DCA90EB6-3D09-4B67-A9CF-31FC31CDA065Q36782652-BD99F57A-00B1-44DB-8585-8F68F80C5BC4Q38824804-EC4EF494-0382-4909-A1D4-94E2DA8A1884Q38846078-68B20F04-8539-44FC-882D-D7A7D8B9D1EDQ41421424-FA0A7C9E-8662-464C-9B8D-4386804CAC75Q46254101-A747C373-9184-4B4F-A5F9-A0ECA25FE773Q46371372-6178CBC6-65B2-466C-A489-F2E215BC1B61Q46859452-27D31B50-2400-4E72-8A39-5220FFC9C5FDQ46917508-3BA1857C-A994-4E2F-8D6D-7E792A2066A1Q47363754-77A4B7E7-8F01-4838-B5C5-A9815E34A3DFQ51023898-CA2FD628-4250-48AC-BD89-9FDAF3A2C37DQ52615620-FBF3EA00-270A-445C-BF36-D739C441E0EDQ52886833-F132185F-345B-4BBE-9BD7-1E8CC193587DQ59806126-345D88C7-BF66-4A71-9ECF-079749D32A3FQ88976865-C3F030AF-7B58-40E9-8AB4-59C6EE40A7DDQ90553998-E4C66255-FD0F-4597-AEEF-87CDF350134CQ92435847-87DCE065-8FF1-469C-9A7A-F22C25412DDB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohammed A. Mansour
@ast
Mohammed A. Mansour
@en
Mohammed A. Mansour
@es
Mohammed A. Mansour
@nl
Mohammed A. Mansour
@sl
type
label
Mohammed A. Mansour
@ast
Mohammed A. Mansour
@en
Mohammed A. Mansour
@es
Mohammed A. Mansour
@nl
Mohammed A. Mansour
@sl
altLabel
Dr Mohammed A. Mansour
@en
prefLabel
Mohammed A. Mansour
@ast
Mohammed A. Mansour
@en
Mohammed A. Mansour
@es
Mohammed A. Mansour
@nl
Mohammed A. Mansour
@sl
P108
P106
P1153
43161253100
P21
P31
P496
0000-0001-8701-4007